1/190
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Other names for a gated blood pool study
MUGA, RVG, RNV, ERNA
Main use of MUGA today
Serial LVEF monitoring during cardiotoxic chemotherapy
Cardiotoxic chemo drugs monitored with MUGA
Anthracyclines (doxorubicin) and trastuzumab (Herceptin)
Why MUGA instead of echo for chemo monitoring?
More reproducible EF (low inter-observer variability)
MUGA radiopharmaceutical and dose
Tc-99m RBCs, 15–30 mCi IV
RBC labeling chemistry
Stannous ion reduces Tc-99m from +7 to +4 so it binds hemoglobin beta chain
RBC labeling: lowest and most variable efficiency
In vivo
RBC labeling: highest and most consistent efficiency
In vitro (UltraTag)
UltraTag step that removes extracellular stannous
Sodium hypochlorite oxidation
Free pertechnetate on MUGA appears in…
Thyroid, stomach, salivary glands, bladder
MUGA frames per cycle for systolic function
Minimum 16; preferred 24–32
MUGA frames per cycle for diastolic function
32–64
MUGA energy window
140 keV ±10%
MUGA total counts
3–7 million total; 200,000–400,000 per frame
Standard MUGA views
Anterior, best-septal LAO (~45°), left lateral
What triggers gated acquisition?
R wave on the ECG
Effect of arrhythmia on MUGA
Degrades gating; beat rejection underestimates EF
Acquisition mode recommended with arrhythmia
List mode
Count-based EF formula
(EDC − ESC) ÷ (EDC − background)
EDC 42,000, ESC 18,000, background 4,000 — LVEF?
63%
Normal LVEF
≥ 50%
Background ROI too close to the LV (over spleen/aorta) effect
Falsely raises EF
Background ROI outside the body effect
Falsely lowers EF
Where is the MUGA background ROI placed?
Lateral to the LV at end-systole
LVEF >50% during chemo
Periodic monitoring — continue
LVEF 30–50% during chemo
More frequent monitoring
LVEF <30% during chemo
Contraindication to continuing cardiotoxic therapy
Stroke volume definition
Volume ejected per contraction (EDV − ESV)
Cardiac output formula
Stroke volume × heart rate
Phase analysis shows…
WHEN each LV region contracts (timing/dyssynchrony)
Amplitude analysis shows…
HOW MUCH each region contracts (strength)
Regurgitation index
LV stroke counts ÷ RV stroke counts (near 1 = normal)
Time per frame formula
(60,000 ÷ HR) ÷ frames per cycle
Stress MUGA exercise equipment
Supine/semi-upright bicycle ergometer (not treadmill)
Normal stress MUGA response
LVEF rises ≥5 percentage points; ESV decreases
Abnormal stress MUGA response
EF flat or falls; new wall-motion abnormality
Pharmacologic agent for a stress blood-pool study
Dobutamine (not vasodilators)
Tl-201 mechanism
Potassium analog — Na+/K+-ATPase active transport
Does Tl-201 redistribute?
Yes — significantly, over 3–4 h
Tc-99m sestamibi/tetrofosmin mechanism
Passive diffusion + mitochondrial trapping (membrane potential)
Do Tc-99m perfusion agents redistribute?
No — fixed; need separate rest and stress injections
1-day Tc-99m MPI order
Rest first (8–12 mCi), then stress ~3× higher (24–36 mCi)
Why must rest come before stress in a 1-day protocol?
Residual rest activity would mask reversible stress defects
2-day Tc-99m MPI dose
25–30 mCi each day
Dual-isotope MPI
Rest Tl-201 (~3–4 mCi) + stress Tc-99m agent
Dual-isotope MPI drawback
Higher total radiation dose
Tl-201 MPI dose
2–4 mCi (reinjection ~1.5 mCi)
Tl-201 stress imaging time
About 10 min post-stress
Tl-201 redistribution imaging time
3–4 hours
Tc-99m MPI imaging time after stress
15–60 min
Tc-99m MPI imaging time after rest injection
60–90 min
Why give a fatty meal or water before Tc-99m MPI imaging?
Clear hepatobiliary activity near the inferior wall
Tl-201 physical half-life
About 73 hours
Breastfeeding interruption after Tl-201
2 weeks
Reversible perfusion defect means…
Ischemia
Fixed perfusion defect means…
Scar/infarct (or attenuation)
Breast attenuation affects which wall?
Anterior
Diaphragmatic attenuation affects which wall?
Inferior
Prone imaging advantage
Reduces inferior-wall diaphragmatic attenuation
Prone imaging disadvantage
Can create anterior/septal (sternal) attenuation
CTAC misregistration signature
False ↑ inferior wall + false ↓ anteroseptal/apex
Fix for CTAC misregistration
Re-register CT to SPECT so LV borders align
Standard cardiac SPECT orbit
180° (45° RAO to 45° LPO)
Cardiac SPECT matrix and pixel size
64 × 64; 6.4 ± 0.2 mm
Common low-pass filter for cardiac SPECT
Butterworth
Reconstruction required for attenuation correction
Iterative reconstruction
8-frame vs 16-frame gated SPECT
8-frame underestimates LVEF by ~3 points; 16 preferred if counts allow
Three standard cardiac reorientation planes
Short axis, vertical long axis, horizontal long axis
Short axis slices look like…
Donuts/rings from apex to base
Vertical long axis shows…
Anterior and inferior walls
Horizontal long axis shows…
Septal and lateral walls
LAD supplies…
Anterior wall, anteroseptum, apex
LCX supplies…
Lateral wall (± posterior)
RCA supplies…
Inferior wall, RV (± posterior in right-dominant)
AHA segment model
17 segments
What is TID?
LV cavity larger on stress than rest images
TID ratio abnormal above about…
1.2
TID suggests…
Severe multivessel / left main CAD
Increased lung uptake on stress Tl-201 indicates…
LV dysfunction / severe CAD (lung:heart >~0.5)
Other high-risk MPI signs
Transient RV visualization, post-stress EF drop, multiple reversible defects
"Balanced ischemia" problem in SPECT
Equal 3-vessel disease can look normal (relative imaging)
Rb-82 half-life
75 seconds
Rb-82 source
Sr-82/Rb-82 generator
Rb-82 dose
20–40 mCi per image set (3D ~20, 2D ~40)
Rb-82 extraction fraction
About 65% (rolls off at high flow)
N-13 ammonia half-life
About 10 minutes
N-13 ammonia source and dose
Cyclotron; 10–20 mCi
N-13 ammonia extraction fraction
About 80%
Rb-82 generator daily QC
Sr-82/Sr-85 breakthrough
Coronary flow reserve formula
Stress MBF ÷ rest MBF
Abnormal coronary flow reserve
Rest MBF 1.0, stress MBF 1.8 — CFR?
1.8 (abnormal)
PET advantage over SPECT for perfusion
Absolute blood flow quantification (catches balanced disease)
Flyrcado radiopharmaceutical
F-18 flurpiridaz (FDA 2024)
Flyrcado mechanism
Binds mitochondrial complex I
Flyrcado advantage
F-18 half-life allows shipping and treadmill exercise stress
Cardiac sarcoid FDG prep
High-fat, very-low-carb diet day before + prolonged fast (± heparin)
Cardiac sarcoid diet numbers
35 g fat, <3 g carbohydrate meals
Diffuse myocardial FDG uptake on sarcoid scan means…
Failed suppression (not disease)
Sarcoid: perfusion defect + focal FDG uptake
Active inflammation (mismatch)